Products - Structural heart defects | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 62 products

Date | Title

Acoramidis for treating transthyretin-related amyloidosis cardiomyopathy ID6354
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissection (IPG733)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
3 August 2022
Aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease (IPG769)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
9 August 2023
Aortic valve reconstruction with processed bovine pericardium (IPG604)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
14 February 2018
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)
Product type:
Guidance
Programme:
Diagnostics guidance
Last updated:
19 December 2017
Published:
24 September 2014
Balloon angioplasty of pulmonary vein stenosis in infants (IPG75)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 July 2004
Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children (IPG74)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 July 2004
Balloon dilatation of pulmonary valve stenosis (IPG67)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 June 2004
Balloon dilatation of systemic to pulmonary arterial shunts in children (IPG77)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 July 2004
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children (IPG76)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 July 2004
Balloon valvuloplasty for aortic valve stenosis in adults and children (IPG78)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 July 2004
Beating heart mitral valve repair by artificial chordae insertion for mitral regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
4 March 2026
Caval valve implantation for tricuspid regurgitation (IPG791)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
21 August 2024
Cor-Knot for tying suture knots in valve surgery (MIB206)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
10 March 2020
Cor-Knot for tying suture knots in valve surgery
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) (DG13)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
20 August 2014
Elamipretide for treating Barth syndrome in people of any age [ID6545]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Endovascular Arch Repair
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Endovascular atrial septostomy (IPG86)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 August 2004
Endovascular closure of atrial septal defect (IPG96)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 October 2004
Endovascular closure of patent ductus arteriosus (IPG97)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 October 2004
Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [TSID12015]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Heart valve disease in adults
Status:
Awaiting development
Expected publication date:
TBC
Heart valve disease presenting in adults: investigation and management (NG208)
Product type:
Guidance
Programme:
NICE guideline
Published:
17 November 2021
Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates (IPG246)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
12 December 2007
Interventional Correction of Superior Sinus Venosus Defect and Partial Anomalous Pulmonary Venous Drainage
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Mavacamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6523]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy (TA913)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
6 September 2023
microINR for anticoagulation therapy (MIB257)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
21 April 2021
microINR for anticoagulation therapy MT592 (MIB257)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Non-surgical reduction of the myocardial septum (IPG40)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 February 2004
Percutaneous balloon valvuloplasty for fetal critical aortic stenosis (IPG613)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
9 May 2018
Percutaneous closure of patent foramen ovale for recurrent migraine (IPG370)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
15 December 2010
Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers (IPG371)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
15 December 2010
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events (IPG472)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
18 December 2013
Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum (IPG176)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 May 2006
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve (IPG700)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 June 2021
Percutaneous mitral valve annuloplasty (IPG352)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 July 2010
Percutaneous mitral valve leaflet repair for mitral regurgitation (IPG649)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
29 May 2019
Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction (IPG436)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 January 2013
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome (IPG724)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
18 May 2022
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (CG64)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
8 July 2016
Published:
17 March 2008
Sutureless aortic valve replacement for aortic stenosis (IPG624)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
22 August 2018
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA984)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
19 June 2024
Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects (IPG505)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 November 2014
The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
11 August 2014
Thoracoscopically assisted mitral valve surgery (IPG245)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
12 December 2007
Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repair (IPG707)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
22 September 2021
Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis (IPG706)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
22 September 2021
Transcatheter aortic valve implantation for aortic stenosis (IPG586)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 July 2017
Transcatheter aortic valve implantation for native aortic valve regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
11 June 2025
Transcatheter endovascular closure of perimembranous ventricular septal defect (IPG336)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 March 2010
Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: Late stage assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
TBC
Transcatheter tricuspid valve annuloplasty for tricuspid regurgitation (IPG730)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 July 2022
Transcatheter tricuspid valve implantation for tricuspid regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
4 March 2026
Transcatheter tricuspid valve leaflet repair for tricuspid regurgitation (IPG731)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 July 2022
Transcatheter Tricuspid Valve Replacement
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Trans-septal transcatheter mitral valve-in-valve implantation for failed surgical mitral valve bioprosthesis
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction (IPG653)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 June 2019
Vutrisiran for treating transthyretin-related amyloidosis cardiomyopathy [ID6470]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
12 November 2025